SteadyMed Ltd. (STDY) Misses Q2 EPS by 7c

SteadyMed Ltd. (NASDAQ: STDY) reported Q2 EPS of ($0.51), $0.07 worse than the analyst estimate of ($0.44).

For earnings history and earnings-related data on SteadyMed Ltd. (STDY) click here.

You May Also Be Interested In

• Walmart (WMT) PT Lowered to $130 at UBS on Investment Narrative's Competing Dynamics
• Deutsche Bank monitors UK auto sales as Chinese exports grow
• Bernstein remains bullish on SpaceX but sees challenges in telecom ambitions